Axial Spondyloarthritis

A treat-to-target strategy in which TNF inhibitors are tapered is non-inferior to a regimen without tapering for maintaining low disease activity in patients with psoriatic arthritis or axial spondyloarthritis, according to data.

Consuming specific dietary components such as vitamin D or omega-3 is “unlikely to influence the progression” of rheumatic and musculoskeletal diseases, according to a report of systemic reviews published in RMD Open.

DESTIN, Fla. — Early treatment can provide patients with axial spondyloarthritis a better opportunity to achieve drug-free remission and slow disease progression, according to a speaker at the Congress of Clinical Rheumatology East 2022.

Gut dysbiosis is more frequent in patients with ankylosing spondylitis, compared with controls, and is associated with worse axial spondyloarthritis disease activity and physical function, according to data.

Patients with axial spondyloarthritis demonstrate significant differences in peripheral and extra-musculoskeletal manifestations based on geographic region, according to data published in Rheumatology.

Nonradiographic axial spondyloarthritis remains an underrecognized and undertreated condition in the United States, with rheumatology often the last stop for many of these patients. However, with a recent ICD-10 code upgrade, that may begin to change.

Patients with self-reported elevated spine symptoms in psoriatic arthritis, with or without a diagnosis of axial disease, had worse quality of life and disease activity overall versus patients without axial manifestations, according to data.

In patients with non-radiographic axial spondyloarthritis, MRI sacroiliitis and HLA-B27 positivity, but not elevated C-reactive protein or responses at week 12, predict long-term certolizumab pegol response, according to data.

While there is a cross-section of drugs that are FDA-approved for the treatment of axial spondyloarthritis, clinicians and researchers continue to struggle with axial psoriatic arthritis, according to a presenter at ACR Convergence 2021.

A newly developed artificial neural network can accurately detect radiographic sacroiliitis in patients with suspected axial spondyloarthritis, according to data presented at ACR Convergence 2021.